New U.S. Trade Deal May Bring Higher Drug Prices to U.K.
- Trump aims to share drug costs, researchers say in Lancet
- U.K. will have less bargaining leverage once outside the EU
A pharmacist looks for medication on a pharmacy's shelves in London.
Photographer: Bloomberg/BloombergThis article is for subscribers only.
U.K. politicians under pressure to clinch a new trade agreement with the U.S. could compromise on the way their country regulates medicines, making prescription drugs more expensive after Brexit, three researchers wrote.
Under President Donald Trump, “American drug pricing policy now has the explicit and unusual goal of making drugs more expensive in other countries,” Holly Jarman, an assistant professor at the University of Michigan’s School of Public Health, and two England-based colleagues said in an article published in the Lancet medical journal on Thursday.